SCHEMBL13014002

SCHEMBL13014002

CCOC(=O)C1=C(C)Nc2c(c(Nc3ccc(Cl)cc3)nc(=O)n2CCOC)C1C

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ABCC1 P33527 1/20 0.42
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
TSHR P16473 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HPGD P15428 2/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
P2RX3 P56373 6/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
PTAFR P25105 1/20 0.38
ALK Q9UM73 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13013580 0.93 SMN1; SMN2 (0.39) ALDH1A1KDM4ETSHRNPSR1P2RX3
SCHEMBL13014273 0.88 ADORA3 (0.47) ABCC1ALDH1A1KDM4EHPGDP2RX3
SCHEMBL13013020 0.88 ABCC1 (0.40) ABCC1ALDH1A1KDM4ETSHRNPSR1
SCHEMBL13013486 0.86 SMN1; SMN2 (0.40) ALDH1A1KDM4ENPSR1HPGDP2RX3
SCHEMBL13013021 0.83 ABCC1 (0.41) ABCC1ALDH1A1KDM4ETSHRNPSR1
SCHEMBL13014289 0.83 ALDH1A1 (0.44) ABCC1ALDH1A1KDM4ETSHRNPSR1
SCHEMBL13013490 0.82 ADORA3 (0.48) ABCC1ALDH1A1KDM4ETSHRNPSR1
SCHEMBL13014278 0.81 BRD4 (0.49) ALDH1A1KDM4ECYP3A4CYP2C9CYP2C19
SCHEMBL13013018 0.81 MEN1 (0.39) ALDH1A1KDM4ETSHRNPSR1HPGD
SCHEMBL13012935 0.80 ADORA3 (0.49) ABCC1ALDH1A1KDM4EHPGDP2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010149786-A1 PYRIDO [2, 3-D] PYRIMIDINES AS WNT ANTAGONISTS FOR TREATMENT OF CANCER AND ARTHRITIS DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2010-12-29 WO disclosed